Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
4 search results for:

Waldenström macroglobulinemia 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 13-08-2018 | Waldenström macroglobulinemia | News | Article

    Ibrutinib monotherapy promising for untreated Waldenström macroglobulinemia

    Phase II trial results suggest that the Bruton tyrosine kinase inhibitor ibrutinib has high activity and is well tolerated in symptomatic, treatment-naïve patients with Waldenström macroglobulinemia.

    Published in:
    J Clin Oncol 2018; doi:10.1200/JCO.2018.78.6426 J Clin Oncol 2018; doi:10.1200/JCO.2018.79.3273
  2. 03-06-2018 | B-cell lymphoma | ASCO 2018 | Article
    News in brief

    Ibrutinib, rituximab duo boosts Waldenström macroglobulinemia outcomes

    Treatment with the combination of ibrutinib and rituximab results in better outcomes for patients with newly diagnosed or recurrent Waldenström macroglobulinemia than rituximab alone, phase III trial findings indicate.

  3. 31-05-2018 | B-cell lymphoma | Article

    Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

    Dimopoulos MA et al.  N Engl J Med  2018; 378(25): 2399-2410. doi:10.1056/NEJMoa1802917

  4. 01-08-2016 | Lymphoma | Article

    Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine

    Its inhibitor, ibrutinib, shows promising efficacy in patients with relapsed/refractory chronic lymphocytic leukemia/small lymohocytic lymphoma, mantle lymphoma, follicular lymphoma, activated B-cell-like diffuse large B-cell lymphoma, lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia, primary diffuse large B-cell lymphoma of the central nervous system, and marginal zone lymphomas which also have aberrant Btk activity. 159, 160 Figure 5.

    Author:
    Ruifang Sun, L Jeffrey Medeiros, Ken H Young
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.